These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 10724839)
1. Radiology's role widens in therapeutic drug development and trials. Batchelder KF Diagn Imaging (San Franc); 1999 Nov; 21(11):205-7, 221. PubMed ID: 10724839 [No Abstract] [Full Text] [Related]
2. Drug combination approved for advanced breast cancer. FDA Consum; 2002; 36(1):5. PubMed ID: 11881602 [No Abstract] [Full Text] [Related]
3. Trastuzumab and capecitabine for metastatic breast cancer. Med Lett Drugs Ther; 1998 Nov; 40(1039):106-8. PubMed ID: 9814369 [No Abstract] [Full Text] [Related]
4. FDA approves new breast cancer treatment. Thompson CA Am J Health Syst Pharm; 2007 Dec; 64(23):2406. PubMed ID: 18029940 [No Abstract] [Full Text] [Related]
5. Lapatinib: new drug. For some women with metastatic breast cancer. Prescrire Int; 2009 Feb; 18(99):9. PubMed ID: 19382400 [No Abstract] [Full Text] [Related]
6. Better prioritization may speed approval of adjuvant therapies in breast cancer. Tuma RS J Natl Cancer Inst; 2008 Jun; 100(12):842-4. PubMed ID: 18544735 [No Abstract] [Full Text] [Related]
7. Application of epothilones in breast cancer therapy. Cianfrocca M Curr Opin Oncol; 2008 Nov; 20(6):634-8. PubMed ID: 18841044 [TBL] [Abstract][Full Text] [Related]
8. Rational development of capecitabine. Twelves C; Anthoney A Semin Oncol; 2000 Oct; 27(5 Suppl 10):144-8. PubMed ID: 11049047 [No Abstract] [Full Text] [Related]
10. [Tumor specific therapy. Targeted breast cancer therapy]. MMW Fortschr Med; 2003 Sep; 145(38):62. PubMed ID: 14603691 [No Abstract] [Full Text] [Related]
11. Elementary, my dear Watson. García-Saénz JA; Martín M; Díaz-Rubio E J Clin Oncol; 2007 May; 25(13):1815-6. PubMed ID: 17470879 [No Abstract] [Full Text] [Related]
12. FDA notifications. NRTI Emtriva receives FDA approval. AIDS Alert; 2003 Oct; 18(10):131-2. PubMed ID: 14686301 [TBL] [Abstract][Full Text] [Related]
13. [Capecitabine--a review of its antitumor activity and toxicity in clinical studies]. Sasaki T; Maeda Y Gan To Kagaku Ryoho; 2000 Jul; 27(8):1307-13. PubMed ID: 10945031 [TBL] [Abstract][Full Text] [Related]
14. Positive results achieved with new oral chemotherapy agent. Timmerman D Oncol Nurs Forum; 1999 May; 26(4):675. PubMed ID: 10337634 [No Abstract] [Full Text] [Related]
15. Bioregulatory niches in breast cancer. Sledge GW Clin Breast Cancer; 2006 Aug; 7(3):200. PubMed ID: 16942636 [No Abstract] [Full Text] [Related]
16. Femara approved as first-line breast cancer therapy. FDA Consum; 2001; 35(3):5. PubMed ID: 11458552 [No Abstract] [Full Text] [Related]
17. Cancer drug approval in the United States, Europe, and Japan. Milsted RA Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686 [No Abstract] [Full Text] [Related]
18. FDA approves new drug for specific type of advanced breast cancer. Mayo Clin Womens Healthsource; 2007 Oct; 11(10):3. PubMed ID: 18418907 [No Abstract] [Full Text] [Related]
19. Dual-action drug approved for use in advanced breast cancer. McBride D ONS Connect; 2007 Jun; 22(6):19. PubMed ID: 17598617 [No Abstract] [Full Text] [Related]
20. Advances in breast cancer treatment: the emerging role of ixabepilone. Frye DK Expert Rev Anticancer Ther; 2010 Jan; 10(1):23-32. PubMed ID: 20014882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]